[Federal Register Volume 59, Number 137 (Tuesday, July 19, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-17475]
[[Page Unknown]]
[Federal Register: July 19, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committee Meeting; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of a meeting of the Antiviral Drugs Advisory
Committee. This meeting was announced in the Federal Register of June
24, 1994 (59 FR 32699 at 32700). The amendment is being made to reflect
a change in the date of the meeting from a 1-day to a 2-day meeting and
a change in the meeting room locations, and to announce a closed
portion of the meeting, which is now scheduled for the second day. The
open committee discussion remains the same, except for the date the
discussions will be held. This amendment will be announced at the
beginning of the open portion of the meeting.
FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger or Valerie Mealy,
Center for Drug Evaluation and Research (HFD-9), Food and Drug
Administration, 5600 Fishers Lane, Rockville MD 20857 301-443-4695.
SUPPLEMENTARY INFORMATION: In the Federal Register of June 24, 1994,
FDA announced that a meeting of the Antiviral Drugs Advisory Committee
would be held on June 29, 1994. On page 32700, in the first column, the
``Date, time, and place'' and ``Type of meeting and contact person''
portions of this meeting are amended, and because the committee will
now have a closed portion on July 29, 1994, a ``Closed committee
deliberations'' portion is added to read as follows:
Date, time, and place. July 28, 1994, 8 a.m., Parklawn Bldg.,
Conference rms. D and E, and July 29, 1994, 8:30 a.m., Parklawn Bldg.,
Conference rms. G, H, I, and J, 5600 Fishers Lane, Rockville, MD.
Type of meeting and contact person. Open committee discussion, July
28, 1994, 8 a.m. to 11 a.m.; open public hearing, 11 a.m. to 12 m.,
unless public participation does not last that long; open committee
discussion, 12 m. to 5 p.m.; closed committee deliberations, July 29,
1994, 8:30 a.m. to 12 m.; Lee L. Zwanziger or Valerie Mealy, Center for
Drug Evaluation and Research (HFD-9), Food and Drug Administration,
5600 Fishers Lane, Rockville, MD 20857, 301-443-4695.
Closed committee deliberations. On July 29, 1994, the committee
will discuss trade secret and/or confidential commercial information
relevant to pending NDA's. This portion of the meeting will be closed
to permit discussion of this information (5 U.S.C. 552b(c)(4)).
Dated: July 13, 1994.
Linda A. Suydam,
Interim Deputy Commissioner for Operations.
[FR Doc. 94-17475 Filed 7-18-94; 8:45 am]
BILLING CODE 4160-01-F
